After the first successful session, the AFPT-CP1 will run the second session of its pre-clinical and clinical safety in early development human trial course in cooperation with EUFEMED, its European Federation, and Paris-Saclay University.

Programme:

AFPT-LCP1_SAFETY_final version_18Nov2022

If you are interested by the programme, you please register:

https://www.csihamburg-meeting.de/AFPT-Training-2023/

This training course will take place from 13-17^th of March 2023 in Saclay in the south of Paris (onsite).

It is a 5-day course on ‘Pre-Clinical and Clinical Safety in Early Development Human Trials’ recognized by Paris-Saclay University and EUFEMED, forming part of a diploma.

It follows the European ‘Pharmatrain’ syllabus, and a certification will be requested in the next future.

It is held in English and is intended for people working in the pharmaceutical industry and students who would like to know more on this sensitive topic.

Do not hesitate to speak of this advanced training to you colleagues who could be interested”